Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jaschonek

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|March 1, 1988
Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclaseK Jaschonek, C Faul, H Schmidt, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Metabolism of 14-C-arachidonic acid in platelets and antiaggregatory potency of prostacyclin in women taking oral contraceptivesK Jaschonek, U Michalski, W Daiss, et al.
Thrombosis and Haemostasis|December 15, 1986
Free fatty acids and platelet prostacyclin bindingK Jaschonek, C P Muller, C Faul, et al.
Biochemical Pharmacology|July 20, 1993
Fish oil preparations rich in docosahexaenoic acid modify platelet responsiveness to prostaglandin-endoperoxide/thromboxane A2 receptor agonistsM Scheurlen, M Kirchner, M R Clemens, et al.
Leukemia|May 1, 1996
Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitorsM A Reuss-Borst, K Jaschonek, C A Müller
Progress in Clinical and Biological Research|January 1, 1989
Modulation of platelet [3H] iloprost binding by cholesterol, dibucaine and pentoxifyllineK Jaschonek, M Funck, C P Muller, et al.
Lancet (London, England)|July 8, 1989
Interaction of fluconazole with cyclosporinG Ehninger, K Jaschonek, U Schuler, et al.
Der Internist|October 1, 1985
[Decrease of antithrombin III and factor Xa inhibitor as the cause of thromboembolism complications in chronic inflammatory intestinal disease]W Daiss, M Scheurlen, H Malchow, et al.
Journal of Neurology|January 16, 2003
Aspirin non-responder status in patients with recurrent cerebral ischemic attacksK Grundmann, K Jaschonek, B Kleine, et al.
International Journal of Immunopharmacology|January 1, 1991
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cellsG Pawelec, G Ehninger, A Rehbein, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|March 1, 1988
Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclaseK Jaschonek, C Faul, H Schmidt, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Metabolism of 14-C-arachidonic acid in platelets and antiaggregatory potency of prostacyclin in women taking oral contraceptivesK Jaschonek, U Michalski, W Daiss, et al.
Thrombosis and Haemostasis|December 15, 1986
Free fatty acids and platelet prostacyclin bindingK Jaschonek, C P Muller, C Faul, et al.
Biochemical Pharmacology|July 20, 1993
Fish oil preparations rich in docosahexaenoic acid modify platelet responsiveness to prostaglandin-endoperoxide/thromboxane A2 receptor agonistsM Scheurlen, M Kirchner, M R Clemens, et al.
Leukemia|May 1, 1996
Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitorsM A Reuss-Borst, K Jaschonek, C A Müller
Progress in Clinical and Biological Research|January 1, 1989
Modulation of platelet [3H] iloprost binding by cholesterol, dibucaine and pentoxifyllineK Jaschonek, M Funck, C P Muller, et al.
Lancet (London, England)|July 8, 1989
Interaction of fluconazole with cyclosporinG Ehninger, K Jaschonek, U Schuler, et al.
Der Internist|October 1, 1985
[Decrease of antithrombin III and factor Xa inhibitor as the cause of thromboembolism complications in chronic inflammatory intestinal disease]W Daiss, M Scheurlen, H Malchow, et al.
Journal of Neurology|January 16, 2003
Aspirin non-responder status in patients with recurrent cerebral ischemic attacksK Grundmann, K Jaschonek, B Kleine, et al.
International Journal of Immunopharmacology|January 1, 1991
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cellsG Pawelec, G Ehninger, A Rehbein, et al.
Pageof 4